See the DrugPatentWatch profile for crestor
Can Crestor (rosuvastatin) cause liver damage?
Crestor (rosuvastatin) can affect liver lab tests, but serious liver injury is uncommon. Statins can raise liver enzymes (especially ALT and AST) in some people. For most patients, mild elevations are temporary and do not reflect true liver damage. When liver injury is discussed with statins, it usually means significant enzyme increases or signs/symptoms of hepatitis (for example, jaundice or dark urine), which are rare.
If liver enzyme levels rise significantly or symptoms of liver problems develop, clinicians typically reassess the medication and may stop or adjust therapy.
What liver test changes are most common with statins?
The usual warning signal is an increase in liver enzymes on blood tests (ALT/AST). These lab changes can occur without symptoms and often get better with continued monitoring, dose reduction, or stopping the drug, depending on severity and persistence.
Who is at higher risk for liver problems with Crestor?
Risk is higher in people with certain baseline factors, such as:
- Pre-existing liver disease
- Heavy alcohol use
- Older age
- Taking other medicines that increase statin exposure
- Higher statin doses
Clinicians often check liver-related labs before starting therapy and repeat testing if there are symptoms or concerning lab results.
What symptoms of liver damage should patients watch for?
Patients are generally advised to seek medical care promptly if they develop possible signs of liver injury, such as:
- Yellowing of skin or eyes (jaundice)
- Dark urine
- Unusual fatigue or weakness
- Loss of appetite
- Persistent nausea or vomiting
- Pain in the upper right abdomen
These symptoms require prompt evaluation, including liver blood tests.
What happens if my liver enzymes go up while on Crestor?
Doctors typically respond based on how high the enzymes rise and whether symptoms are present. Common approaches include:
- Rechecking liver enzymes to confirm and track the trend
- Reducing the dose
- Temporarily holding the medication
- Stopping Crestor if injury is suspected
- Switching to a different lipid-lowering strategy if needed
Is this why people get routine liver monitoring on statins?
Practice varies by clinician and patient risk. Many monitoring plans focus on testing before starting and then testing if symptoms occur or if labs were abnormal. The key point is that routine symptoms matter more than occasional, small, temporary lab changes.
Does Crestor interact with other drugs that could raise liver risk?
Drug interactions that increase rosuvastatin levels can raise the chance of side effects, including liver-related lab abnormalities. If you take other medications (including prescription drugs, over-the-counter products, or supplements), it’s important to review them with your prescriber or pharmacist.
How does Crestor compare with other statins for liver risk?
Statins as a class can raise liver enzymes, and serious liver injury is rare with all of them. The overall risk pattern is broadly similar across statins, though specific drugs, doses, and patient risk factors can change how likely liver issues are for an individual.
Where to check patent/regulatory history for Crestor?
For broader product and regulatory reference work (including history that may be relevant to how the drug is marketed and labeled), you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/p/crestor-cancer/
Sources
No sources were provided with your question, so I did not cite any. If you share the information page or prescribing label you’re using (or the country), I can align the answer to the exact language from that source.